Liver function tests and fibrosis scores in a rural population in Africa

This is a dataset to support an analysis to estimate the prevalence and aetiology of liver disease in a rural population in Uganda. The data were collected in 2011 from the Uganda General Population Cohort (GPC), based in Kyamulibwa, in the Kalungu district of South-Western Uganda, established in 1989 (partners: UK Medical Research Council, Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine). We have assessed the prevalence of liver disease based on liver function tests (LFTs) and fibrosis scores, and estimated the burden of liver disease associated with alcohol, hepatitis b virus (HBV), HIV, and high or low body mass index.

[1]  S. Vento,et al.  Liver cirrhosis in sub-Saharan Africa: neglected, yet important. , 2018, The Lancet. Global health.

[2]  P. Klenerman,et al.  Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort , 2018, BMC Infectious Diseases.

[3]  M. Tag-Adeen,et al.  Assessment of liver fibrosis in Egyptian chronic hepatitis B patients , 2018, Medicine.

[4]  B. Jia,et al.  Non‐invasive fibrosis markers for chronic hepatitis B in sub‐Saharan Africa , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[5]  N. Berhe,et al.  Are non‐invasive fibrosis markers for chronic hepatitis B reliable in sub‐Saharan Africa? , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[6]  H. Whittle,et al.  Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. , 2016, The Lancet. Global health.

[7]  Swastik Agrawal,et al.  Evaluation of abnormal liver function tests , 2003, Postgraduate medical journal.

[8]  M. Sonderup,et al.  Health disparities in liver disease in sub‐Saharan Africa , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[9]  G. Cooke,et al.  The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa , 2015, Gut.

[10]  A. Murray,et al.  A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes , 2015, European journal of gastroenterology & hepatology.

[11]  R. Nsubuga,et al.  Sociodemographic distribution of non-communicable disease risk factors in rural Uganda: a cross-sectional study. , 2013, International journal of epidemiology.

[12]  K. Sikaris,et al.  The de ritis ratio: the test of time. , 2013, The Clinical biochemist. Reviews.

[13]  Xianzhang Huang,et al.  First Definition of Reference Intervals of Liver Function Tests in China: A Large-Population-Based Multi-Center Study about Healthy Adults , 2013, PloS one.

[14]  William M. Lee,et al.  Diagnosis of alcohol misuse and alcoholic liver disease among patients in the medical emergency admission service of a large urban hospital in Sub-Saharan Africa; a cross sectional study , 2013, The Pan African medical journal.

[15]  S. Lewin,et al.  Human immunodeficiency virus infection and the liver. , 2012, World journal of hepatology.

[16]  Philip Hall,et al.  What is the Real Function of the Liver ‘Function’ Tests? , 2012, The Ulster medical journal.

[17]  C. Thio,et al.  Liver disease in the HIV-infected individual. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  Yan Liu,et al.  Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment , 2010, Environmental health perspectives.

[19]  S. Caldwell,et al.  Epidemiology and natural history of non-alcoholic steatohepatitis. , 2009, Clinics in liver disease.

[20]  J. L. Fuentes-Allen,et al.  Correlation between HIV viral load and aminotransferases as liver damage markers in HIV infected naive patients: a concordance cross-sectional study , 2009, Virology Journal.

[21]  J. Goedert,et al.  Aflatoxin Exposure and Viral Hepatitis in the Etiology of Liver Cirrhosis in The Gambia, West Africa , 2008, Environmental health perspectives.

[22]  A. Kamali,et al.  Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials , 2008, PloS one.

[23]  R. Sterling,et al.  The Prevalence and Risk Factors for Abnormal Liver Enzymes in HIV-Positive Patients without Hepatitis B or C Coinfections , 2008, Digestive Diseases and Sciences.

[24]  P. Hyltoft Petersen,et al.  The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties , 2004, Scandinavian journal of clinical and laboratory investigation.

[25]  A. Watson.  Liver function tests (LFTs) , 2000, Australian family physician.